Balanced news tone
News Sentiment
LKFT sentiment intelligence
Lakefront Biotherapeutics NV news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
70/100 classification confidence.
directly relevant articles
high-authority source matches
-1.7% over one week, +5.4% over four weeks, trend inactive, and near fair-value range.
What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
What You Need To Know About The Lakefront Biotherapeutics NV (AMS:LKFT) Analyst Downgrade Today
- Tone
- Negative 34/100
- Event
- Analyst action
- Published
- 14 Jul 2026 04:18
- Source
- simplywall.st
[6-K] Lakefront Biotherapeutics NV Current Report (Foreign Issuer) | LKFT SEC Filing - Form 6-K
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 20:33
- Source
- Stock Titan
Lakefront Announces Paulo Fontoura has Resigned from its Board following his Appointment as Global Head of R&D at Sanofi
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 20:01
- Source
- marketscreener.com
Lakefront Biotherapeutics (LKFT) Coverage Resumed by Morgan Stan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 17:33
- Source
- GuruFocus
Lakefront draws Equal Weight rating at Morgan Stanley (LKFT)
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 10 Jul 2026 16:41
- Source
- Seeking Alpha
Lakefront Announces Initiation of €50 Million Stock Repurchase Program
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 09 Jun 2026 07:00
- Source
- marketscreener.com
Lakefront Biotherapeutics NV: Target Price Consensus and Analysts Recommendations | LKFT | BE0003818359
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 28 May 2026 15:18
- Source
- marketscreener.com
Lakefront Biotherapeutics American Depositary Shares (LKFT) Earnings Date and Reports 2026
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 10 May 2026 05:12
- Source
- MarketBeat
Lakefront Biotherapeutics NV 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:LKFT) 2026-05-09
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 09 May 2026 07:00
- Source
- Seeking Alpha